These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 667049)

  • 1. Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier.
    Devés R; Krupka RM
    Biochim Biophys Acta; 1978 Jul; 510(2):339-48. PubMed ID: 667049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts.
    Jung CY; Rampal AL
    J Biol Chem; 1977 Aug; 252(15):5456-63. PubMed ID: 885863
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B.
    Carruthers A; Helgerson AL
    Biochemistry; 1991 Apr; 30(16):3907-15. PubMed ID: 2018762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric binding of steroids to internal and external sites in the glucose carrier of erythrocytes.
    Krupka RM; Devés R
    Biochim Biophys Acta; 1980 May; 598(1):134-44. PubMed ID: 7417422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical binding of phloretin to the glucose transport system of human erythrocytes.
    Krupka RM
    J Membr Biol; 1985; 83(1-2):71-80. PubMed ID: 4039758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochalasin B binding to Ehrlich ascites tumor cells and its relationship to glucose carrier.
    Cuppoletti J; Mayhew E; Jung CY
    Biochim Biophys Acta; 1981 Apr; 642(2):392-404. PubMed ID: 7284364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing transport systems for competition between pairs of reversible inhibitors. Inhibition of erythrocyte glucose transport by cytochalasin B and steroids.
    Devés R; Krupka RM
    J Biol Chem; 1980 Dec; 255(24):11870-4. PubMed ID: 7440574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochalasin B-binding proteins in rabbit erythrocyte membranes and their post-natal change in relation to the glucose carrier activity.
    Jung CY; Pinkofsky HB; Cowden MW
    Biochim Biophys Acta; 1980 Mar; 597(1):145-54. PubMed ID: 7370240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose transport carrier of human erythrocytes. Radiation-target size of glucose-sensitive cytochalasin B binding protein.
    Jung CY; Hsu TL; Hah JS; Cha C; Haas MN
    J Biol Chem; 1980 Jan; 255(2):361-4. PubMed ID: 7356617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors.
    Basketter DA; Widdas WF
    J Physiol; 1978 May; 278():389-401. PubMed ID: 671319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric or symmetric? Cytosolic modulation of human erythrocyte hexose transfer.
    Carruthers A; Melchior DL
    Biochim Biophys Acta; 1983 Feb; 728(2):254-66. PubMed ID: 6681982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochalasin B does not serve as a marker of glucose transport in rabbit erythrocytes.
    Albert SG
    Biochem Int; 1984 Jul; 9(1):93-103. PubMed ID: 6541046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible association of cytochalasin B with the human erythrocyte membrane. Inhibition of glucose transport and the stoichiometry of cytochalasin binding.
    Taverna RD; Langdon RG
    Biochim Biophys Acta; 1973 Oct; 323(2):207-19. PubMed ID: 4752283
    [No Abstract]   [Full Text] [Related]  

  • 14. The monosaccharide transport system of the human erythrocyte. Solubilization and characterization on the basis of cytochalasin B binding.
    Zoccoli MA; Baldwin SA; Lienhard GE
    J Biol Chem; 1978 Oct; 253(19):6923-30. PubMed ID: 690133
    [No Abstract]   [Full Text] [Related]  

  • 15. Human erythrocyte sugar transport is incompatible with available carrier models.
    Cloherty EK; Heard KS; Carruthers A
    Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for allosteric inhibition sites in the glucose carrier of erythrocytes.
    Krupka RM; Devés R
    Biochim Biophys Acta; 1980 May; 598(1):127-33. PubMed ID: 7417421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane effects of cytochalasin B. Competitive inhibition of facilitated diffusion processes in rat hepatoma cells and other cell lines and effect on formation of functional transport sites.
    Plagemann PG; Zylka JH; Erbe J; Estensen RD
    J Membr Biol; 1975 Aug; 23(1):77-90. PubMed ID: 1165581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes.
    Rampal AL; Pinkofsky HB; Jung CY
    Biochemistry; 1980 Feb; 19(4):679-83. PubMed ID: 7356953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cytochalasin B binding to adult rat liver parenchymal cells in primary culture.
    Gross RL; Kletzien RF; Butcher FR
    Biochim Biophys Acta; 1980 Nov; 602(3):635-43. PubMed ID: 7437425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochalasin B inhibition of brain glucose transport and the influence of blood components on inhibitor concentration.
    Drewes LR; Horton RW; Betz AL; Gilboe DD
    Biochim Biophys Acta; 1977 Dec; 471(3):477-86. PubMed ID: 921993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.